Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P33
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-1.54%
202314.31%
2022104.63%
2021-134.86%
20200.00%
2019-100.00%
20180.00%